Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487461 · ClinicalTrials.gov registry record · NA
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00487461 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 25 participants.
The verdict
NCT00487461, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether treatment with a drug called Simvastatin prevents and improves outcome in patients who have Subarachnoid bleeding. Simvastatin is currently approved for the treatment of high cholesterol levels.
Interventions
- DRUG Placebo
- DRUG Simvastatin 40 mg
- DRUG Simvastatin 80 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00487461
The ClinicalTrials.gov registry entry for NCT00487461 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00487461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00487461 about?
NCT00487461 is a clinical study titled "Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage". The purpose of this study is to test whether treatment with a drug called Simvastatin prevents and improves outcome in patients who have Subarachnoid bleeding. Simvastatin is currently approved for the treatment of high cholesterol levels.
What is the current status of trial NCT00487461?
This trial is currently terminated. It is a NA study. The enrollment target is 25 participants. The study started on 2007-05. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00487461?
The interventions under investigation include: Placebo (DRUG), Simvastatin 40 mg (DRUG), Simvastatin 80 mg (DRUG).
Who is sponsoring clinical trial NCT00487461?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.